ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-12G9085
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Outlook 2022
BUY CHAPTERS

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-12G9085
Report
June 2025
Pages:175
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ASCENT CORPORATION
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
Qilu Animal Health Products Co., Ltd.
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis Inc
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.
Boehringer Ingelheim

Swine Reproductive and Respiratory Syndrome Vaccine Market Size

In 2024, the global market size of Swine Reproductive and Respiratory Syndrome Vaccine was estimated to be worth US$ 515 million and is forecast to reach approximately US$ 1006 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.

Swine Reproductive and Respiratory Syndrome Vaccine Market

Swine Reproductive and Respiratory Syndrome Vaccine Market

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.
Boehringer ingelheim is the company with the largest market share, about 25 percent.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Reproductive and Respiratory Syndrome Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Reproductive and Respiratory Syndrome Vaccine.
The Swine Reproductive and Respiratory Syndrome Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Reproductive and Respiratory Syndrome Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Reproductive and Respiratory Syndrome Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Swine Reproductive and Respiratory Syndrome Vaccine Market Report

Report Metric Details
Report Name Swine Reproductive and Respiratory Syndrome Vaccine Market
CAGR 10.2%
Segment by Type
  • Active Vaccine
  • Inactivated Vaccines
Segment by Application
  • Government Tender
  • Market Sales
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ASCENT CORPORATION, Boehringer-Ingelheim, MSD Animal Health, SPAH, Ceva, Chengdu TECH-BANK Biological Products Co,.Ltd, ringpu, QILU ANIMAL HEALTH PRODUCTS CO.,LTD, DAHUANONG, CAVAC, Komipharm, Agrovet, Bioveta, JINYU BIO-TECNOLOGY CO.,LTD, Phibro Animal Health, ANHUI TIANKANG(GROUP)SHRES O., LTD, Zoetis, WINSUN BIO, PULIKE BIOLOGICAL ENGINERING,INC.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Swine Reproductive and Respiratory Syndrome Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Swine Reproductive and Respiratory Syndrome Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Reproductive and Respiratory Syndrome Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

Who are the main players in the Swine Reproductive and Respiratory Syndrome Vaccine Market report?

Ans: The main players in the Swine Reproductive and Respiratory Syndrome Vaccine Market are ASCENT CORPORATION, Boehringer-Ingelheim, MSD Animal Health, SPAH, Ceva, Chengdu TECH-BANK Biological Products Co,.Ltd, ringpu, QILU ANIMAL HEALTH PRODUCTS CO.,LTD, DAHUANONG, CAVAC, Komipharm, Agrovet, Bioveta, JINYU BIO-TECNOLOGY CO.,LTD, Phibro Animal Health, ANHUI TIANKANG(GROUP)SHRES O., LTD, Zoetis, WINSUN BIO, PULIKE BIOLOGICAL ENGINERING,INC.

What are the Application segmentation covered in the Swine Reproductive and Respiratory Syndrome Vaccine Market report?

Ans: The Applications covered in the Swine Reproductive and Respiratory Syndrome Vaccine Market report are Government Tender, Market Sales

What are the Type segmentation covered in the Swine Reproductive and Respiratory Syndrome Vaccine Market report?

Ans: The Types covered in the Swine Reproductive and Respiratory Syndrome Vaccine Market report are Active Vaccine, Inactivated Vaccines

1 Study Coverage
1.1 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Active Vaccine
1.2.3 Inactivated Vaccines
1.3 Market by Application
1.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Estimates and Forecasts
2.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2020-2031
2.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales 2020-2031
2.2 Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region: 2024 Versus 2031
2.3 Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2020-2031)
2.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2020-2025
2.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2020-2031)
2.4 Swine Reproductive and Respiratory Syndrome Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2020-2025
2.4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Swine Reproductive and Respiratory Syndrome Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2031)
3.2.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 Swine Reproductive and Respiratory Syndrome Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Active Vaccine of Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application
3.3.2 Inactivated Vaccines of Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application
4 Global Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturers
4.1 Global Top Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Swine Reproductive and Respiratory Syndrome Vaccine Market
4.5.3 Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Product Type and Application
4.5.4 Active Vaccine Market Sales of Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturer
4.5.5 Inactivated Vaccines Market Sales of Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 ASCENT CORPORATION
5.1.1 ASCENT CORPORATION Company Information
5.1.2 ASCENT CORPORATION Description, Business Overview
5.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.1.4 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.1.6 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.1.7 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.1.8 ASCENT CORPORATION Recent Developments
5.2 Boehringer-Ingelheim
5.2.1 Boehringer-Ingelheim Company Information
5.2.2 Boehringer-Ingelheim Description, Business Overview
5.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.2.4 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.2.6 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.2.7 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.2.8 Boehringer-Ingelheim Recent Developments
5.3 MSD Animal Health
5.3.1 MSD Animal Health Company Information
5.3.2 MSD Animal Health Description, Business Overview
5.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.3.4 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.3.6 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.3.7 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.3.8 MSD Animal Health Recent Developments
5.4 SPAH
5.4.1 SPAH Company Information
5.4.2 SPAH Description, Business Overview
5.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.4.4 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.4.6 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.4.7 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.4.8 SPAH Recent Developments
5.5 Ceva
5.5.1 Ceva Company Information
5.5.2 Ceva Description, Business Overview
5.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.5.4 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.5.6 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.5.7 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.5.8 Ceva Recent Developments
5.6 Chengdu TECH-BANK Biological Products Co,.Ltd
5.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
5.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Description, Business Overview
5.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.6.6 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.6.7 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.6.8 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments
5.7 ringpu
5.7.1 ringpu Company Information
5.7.2 ringpu Description, Business Overview
5.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.7.4 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.7.6 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.7.7 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.7.8 ringpu Recent Developments
5.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
5.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
5.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Description, Business Overview
5.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.8.6 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.8.7 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.8.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments
5.9 DAHUANONG
5.9.1 DAHUANONG Company Information
5.9.2 DAHUANONG Description, Business Overview
5.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.9.4 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.9.6 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.9.7 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.9.8 DAHUANONG Recent Developments
5.10 CAVAC
5.10.1 CAVAC Company Information
5.10.2 CAVAC Description, Business Overview
5.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.10.4 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.10.5 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.10.6 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.10.7 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.10.8 CAVAC Recent Developments
5.11 Komipharm
5.11.1 Komipharm Company Information
5.11.2 Komipharm Description, Business Overview
5.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.11.4 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.11.6 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.11.7 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.11.8 Komipharm Recent Developments
5.12 Agrovet
5.12.1 Agrovet Company Information
5.12.2 Agrovet Description, Business Overview
5.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.12.4 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.12.6 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.12.7 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.12.8 Agrovet Recent Developments
5.13 Bioveta
5.13.1 Bioveta Company Information
5.13.2 Bioveta Description, Business Overview
5.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.13.4 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.13.6 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.13.7 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.13.8 Bioveta Recent Developments
5.14 JINYU BIO-TECNOLOGY CO.,LTD
5.14.1 JINYU BIO-TECNOLOGY CO.,LTD Company Information
5.14.2 JINYU BIO-TECNOLOGY CO.,LTD Description, Business Overview
5.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.14.4 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.14.5 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.14.6 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.14.7 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.14.8 JINYU BIO-TECNOLOGY CO.,LTD Recent Developments
5.15 Phibro Animal Health
5.15.1 Phibro Animal Health Company Information
5.15.2 Phibro Animal Health Description, Business Overview
5.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.15.4 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.15.6 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.15.7 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.15.8 Phibro Animal Health Recent Developments
5.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
5.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
5.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Description, Business Overview
5.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.16.6 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.16.7 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.16.8 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments
5.17 Zoetis
5.17.1 Zoetis Company Information
5.17.2 Zoetis Description, Business Overview
5.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.17.4 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.17.5 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.17.6 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.17.7 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.17.8 Zoetis Recent Developments
5.18 WINSUN BIO
5.18.1 WINSUN BIO Company Information
5.18.2 WINSUN BIO Description, Business Overview
5.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.18.4 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.18.5 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.18.6 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.18.7 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.18.8 WINSUN BIO Recent Developments
5.19 PULIKE BIOLOGICAL ENGINERING,INC.
5.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Company Information
5.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Description, Business Overview
5.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
5.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales by Product in 2024
5.19.6 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application in 2024
5.19.7 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Area in 2024
5.19.8 PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments
6 North America
6.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2020-2031
6.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
6.2.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2031)
6.2.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2031)
6.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025)
6.4 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
8.2.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2031)
8.2.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2031)
8.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025)
8.4 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
9.2.1 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2031)
9.3 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025)
9.4 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Swine Reproductive and Respiratory Syndrome Vaccine Supply Chain Analysis
11.2 Swine Reproductive and Respiratory Syndrome Vaccine Key Raw Materials and Upstream Suppliers
11.3 Swine Reproductive and Respiratory Syndrome Vaccine Clients Analysis
11.4 Swine Reproductive and Respiratory Syndrome Vaccine Sales Channel and Sales Model Analysis
11.4.1 Swine Reproductive and Respiratory Syndrome Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Swine Reproductive and Respiratory Syndrome Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
12 Swine Reproductive and Respiratory Syndrome Vaccine Market Dynamics
12.1 Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends
12.2 Swine Reproductive and Respiratory Syndrome Vaccine Market Drivers
12.3 Swine Reproductive and Respiratory Syndrome Vaccine Market Challenges
12.4 Swine Reproductive and Respiratory Syndrome Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
ASCENT CORPORATION
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
Qilu Animal Health Products Co., Ltd.
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis Inc
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.
Boehringer Ingelheim
List of Tables
 Table 1. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2020-2025) & (K Units)
 Table 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Manufacturer (2020-2025)
 Table 18. Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Swine Reproductive and Respiratory Syndrome Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Reproductive and Respiratory Syndrome Vaccine as of 2024)
 Table 24. Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Swine Reproductive and Respiratory Syndrome Vaccine Market
 Table 26. Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. ASCENT CORPORATION Company Information
 Table 29. ASCENT CORPORATION Description and Business Overview
 Table 30. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 31. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. ASCENT CORPORATION Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 33. ASCENT CORPORATION Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 34. ASCENT CORPORATION Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 35. ASCENT CORPORATION Recent Developments
 Table 36. Boehringer-Ingelheim Company Information
 Table 37. Boehringer-Ingelheim Description and Business Overview
 Table 38. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 39. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Boehringer-Ingelheim Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 41. Boehringer-Ingelheim Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 42. Boehringer-Ingelheim Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 43. Boehringer-Ingelheim Recent Developments
 Table 44. MSD Animal Health Company Information
 Table 45. MSD Animal Health Description and Business Overview
 Table 46. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 47. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. MSD Animal Health Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 49. MSD Animal Health Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 50. MSD Animal Health Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 51. MSD Animal Health Recent Developments
 Table 52. SPAH Company Information
 Table 53. SPAH Description and Business Overview
 Table 54. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 55. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. SPAH Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 57. SPAH Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 58. SPAH Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 59. SPAH Recent Developments
 Table 60. Ceva Company Information
 Table 61. Ceva Description and Business Overview
 Table 62. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 63. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Ceva Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 65. Ceva Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 66. Ceva Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 67. Ceva Recent Developments
 Table 68. Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
 Table 69. Chengdu TECH-BANK Biological Products Co,.Ltd Description and Business Overview
 Table 70. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 71. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Chengdu TECH-BANK Biological Products Co,.Ltd Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 73. Chengdu TECH-BANK Biological Products Co,.Ltd Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 74. Chengdu TECH-BANK Biological Products Co,.Ltd Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 75. Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments
 Table 76. ringpu Company Information
 Table 77. ringpu Description and Business Overview
 Table 78. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 79. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. ringpu Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 81. ringpu Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 82. ringpu Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 83. ringpu Recent Developments
 Table 84. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
 Table 85. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Description and Business Overview
 Table 86. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 87. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 89. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 90. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 91. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments
 Table 92. DAHUANONG Company Information
 Table 93. DAHUANONG Description and Business Overview
 Table 94. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 95. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. DAHUANONG Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 97. DAHUANONG Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 98. DAHUANONG Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 99. DAHUANONG Recent Developments
 Table 100. CAVAC Company Information
 Table 101. CAVAC Description and Business Overview
 Table 102. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 103. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. CAVAC Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 105. CAVAC Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 106. CAVAC Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 107. CAVAC Recent Developments
 Table 108. Komipharm Company Information
 Table 109. Komipharm Description and Business Overview
 Table 110. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 111. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 112. Komipharm Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 113. Komipharm Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 114. Komipharm Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 115. Komipharm Recent Developments
 Table 116. Agrovet Company Information
 Table 117. Agrovet Description and Business Overview
 Table 118. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 119. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 120. Agrovet Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 121. Agrovet Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 122. Agrovet Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 123. Agrovet Recent Developments
 Table 124. Bioveta Company Information
 Table 125. Bioveta Description and Business Overview
 Table 126. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 127. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Bioveta Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 129. Bioveta Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 130. Bioveta Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 131. Bioveta Recent Developments
 Table 132. JINYU BIO-TECNOLOGY CO.,LTD Company Information
 Table 133. JINYU BIO-TECNOLOGY CO.,LTD Description and Business Overview
 Table 134. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 135. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 136. JINYU BIO-TECNOLOGY CO.,LTD Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 137. JINYU BIO-TECNOLOGY CO.,LTD Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 138. JINYU BIO-TECNOLOGY CO.,LTD Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 139. JINYU BIO-TECNOLOGY CO.,LTD Recent Developments
 Table 140. Phibro Animal Health Company Information
 Table 141. Phibro Animal Health Description and Business Overview
 Table 142. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 143. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 144. Phibro Animal Health Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 145. Phibro Animal Health Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 146. Phibro Animal Health Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 147. Phibro Animal Health Recent Developments
 Table 148. ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
 Table 149. ANHUI TIANKANG(GROUP)SHRES O., LTD Description and Business Overview
 Table 150. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 151. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 152. ANHUI TIANKANG(GROUP)SHRES O., LTD Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 153. ANHUI TIANKANG(GROUP)SHRES O., LTD Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 154. ANHUI TIANKANG(GROUP)SHRES O., LTD Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 155. ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments
 Table 156. Zoetis Company Information
 Table 157. Zoetis Description and Business Overview
 Table 158. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 159. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 160. Zoetis Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 161. Zoetis Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 162. Zoetis Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 163. Zoetis Recent Developments
 Table 164. WINSUN BIO Company Information
 Table 165. WINSUN BIO Description and Business Overview
 Table 166. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 167. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 168. WINSUN BIO Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 169. WINSUN BIO Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 170. WINSUN BIO Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 171. WINSUN BIO Recent Developments
 Table 172. PULIKE BIOLOGICAL ENGINERING,INC. Company Information
 Table 173. PULIKE BIOLOGICAL ENGINERING,INC. Description and Business Overview
 Table 174. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 175. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 176. PULIKE BIOLOGICAL ENGINERING,INC. Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Product in 2024
 Table 177. PULIKE BIOLOGICAL ENGINERING,INC. Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Application in 2024
 Table 178. PULIKE BIOLOGICAL ENGINERING,INC. Sales Proportion of Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Area in 2024
 Table 179. PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments
 Table 180. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2025) & (K Units)
 Table 181. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2026-2031) & (K Units)
 Table 182. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 183. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 184. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025) & (K Units)
 Table 185. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025) & (K Units)
 Table 186. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2020-2025) & (K Units)
 Table 187. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2026-2031) & (K Units)
 Table 188. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 189. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 190. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025) & (K Units)
 Table 191. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025) & (K Units)
 Table 192. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2025) & (K Units)
 Table 193. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2026-2031) & (K Units)
 Table 194. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 195. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 196. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025) & (K Units)
 Table 197. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025) & (K Units)
 Table 198. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2025) & (K Units)
 Table 199. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2026-2031) & (K Units)
 Table 200. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 201. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 202. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025) & (K Units)
 Table 203. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025) & (K Units)
 Table 204. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2025) & (K Units)
 Table 205. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2026-2031) & (K Units)
 Table 206. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 207. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 208. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025) & (K Units)
 Table 209. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025) & (K Units)
 Table 210. Swine Reproductive and Respiratory Syndrome Vaccine Key Raw Materials, Industry Status and Trend
 Table 211. Swine Reproductive and Respiratory Syndrome Vaccine Key Raw Materials and Upstream Suppliers
 Table 212. Swine Reproductive and Respiratory Syndrome Vaccine Clients Status and Trend
 Table 213. Swine Reproductive and Respiratory Syndrome Vaccine Typical Clients
 Table 214. Swine Reproductive and Respiratory Syndrome Vaccine Distributors
 Table 215. Swine Reproductive and Respiratory Syndrome Vaccine Market Trends
 Table 216. Swine Reproductive and Respiratory Syndrome Vaccine Market Drivers
 Table 217. Swine Reproductive and Respiratory Syndrome Vaccine Market Challenges
 Table 218. Swine Reproductive and Respiratory Syndrome Vaccine Market Restraints
 Table 219. Research Programs/Design for This Report
 Table 220. Key Data Information from Secondary Sources
 Table 221. Key Data Information from Primary Sources
 Table 222. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Swine Reproductive and Respiratory Syndrome Vaccine Product Picture
 Figure 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type in 2024 & 2031
 Figure 4. Active Vaccine Product Picture
 Figure 5. Inactivated Vaccines Product Picture
 Figure 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application in 2024 & 2031
 Figure 8. Government Tender
 Figure 9. Market Sales
 Figure 10. Swine Reproductive and Respiratory Syndrome Vaccine Report Years Considered
 Figure 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size 2020-2031 (US$ Million)
 Figure 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales 2020-2031 (K Units)
 Figure 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2020-2031)
 Figure 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Swine Reproductive and Respiratory Syndrome Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Swine Reproductive and Respiratory Syndrome Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 22. Active Vaccine of Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Inactivated Vaccines of Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Manufacturer in 2024
 Figure 25. Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Active Vaccine Market Sales Proportion by Manufacturer in 2024
 Figure 27. Inactivated Vaccines Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2020-2031 (US$ Million)
 Figure 29. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2020-2025)
 Figure 30. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2020-2025)
 Figure 36. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2020-2031)
 Figure 38. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2020-2025)
 Figure 40. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2020-2025)
 Figure 41. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2020-2025)
 Figure 45. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2020-2025)
 Figure 51. Swine Reproductive and Respiratory Syndrome Vaccine Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of Swine Reproductive and Respiratory Syndrome Vaccine Raw Materials by Region in 2024
 Figure 53. Swine Reproductive and Respiratory Syndrome Vaccine Distribution Channels
 Figure 54. Global Swine Reproductive and Respiratory Syndrome Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global Swine Reproductive and Respiratory Syndrome Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Vaccine for Porcine Reproductive and Respiratory Syndrome PRRS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine Live Market Research Report 2025
Swine Respiratory Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Porcine Reproductive Respiratory Syndrome PRRS Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Streptococcus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Vaccines Market Insights Forecast to 2030
Global Porcine Reproductive and Respiratory Syndrome Test Kit Market Research Report 2024
Swine Flu Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Mycoplasma Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Swine Parvovirus Disease Vaccine Market Research Report 2024
Global PRRS Test Kit Market Research Report 2024
Hog Cholera Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Swine Fever Vaccine Market Insights Forecast to 2030
Swine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Porcine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Infectious Disease Diagnostics Market Insights Forecast to 2030
Swine Respiratory Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pneumonia Vaccine Market Insights Forecast to 2030
Global Cattle Respiratory Vaccines Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions